Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years

Khalid Hussain AL-Qahtani,1 Mutahir A Tunio,2 Mushabbab Al Asiri,2 Yasser Bayoumi,3 Ali Balbaid,2 Naji J Aljohani,4 Hanadi Fatani5 1Department of Otolaryngology-Head & Neck Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Department of Radiation Oncology, Comprehen...

Description complète

Détails bibliographiques
Auteurs principaux: AL-Qahtani KH, Tunio MA, Asiri MA, Bayoumi Y, Balbaid A, Aljohani NJ, Fatani H
Format: Article
Langue:English
Publié: Dove Medical Press 2016-08-01
Collection:Clinical Interventions in Aging
Sujets:
Accès en ligne:https://www.dovepress.com/comparative-clinicopathological-and-outcome-analysis-of-differentiated-peer-reviewed-article-CIA
_version_ 1831592435821576192
author AL-Qahtani KH
Tunio MA
Asiri MA
Bayoumi Y
Balbaid A
Aljohani NJ
Fatani H
author_facet AL-Qahtani KH
Tunio MA
Asiri MA
Bayoumi Y
Balbaid A
Aljohani NJ
Fatani H
author_sort AL-Qahtani KH
collection DOAJ
description Khalid Hussain AL-Qahtani,1 Mutahir A Tunio,2 Mushabbab Al Asiri,2 Yasser Bayoumi,3 Ali Balbaid,2 Naji J Aljohani,4 Hanadi Fatani5 1Department of Otolaryngology-Head & Neck Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Department of Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia; 3Department of Radiation Oncology, NCI, Cairo University, Cairo, Egypt; 4Department of Endocrinology and Thyroid Oncology, 5Histopathology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia Introduction: The aim of this study was to evaluate the treatment outcomes of differentiated thyroid cancer in Saudi patients aged above 60 years. Materials and methods: Comparative analysis was performed in 252 patients aged 46–60 years (Group A) and 118 patients aged above 60 years (Group B), who had thyroidectomy, radioactive iodine-131, and thyroid-stimulating hormone suppression therapy between July 2000 and December 2012. Different clinicopathological features, treatment, complications, disease-free survival, and overall survival rates were compared. Results: Mean age of patients in Group A was 51.9 years (range: 46–60), and mean age of those in Group B was 68.6 years (range: 62–97). Group B patients had higher positive lymph nodes (43.2%), P=0.011. The frequency of extrathyroidal extension, multifocality, and lymphovascular space invasion was seen more in Group B than in Group A. Postsurgical complications (permanent hypoparathyroidism, bleeding, and wound infections) were also seen more in Group B (P=0.043, P=0.011, and P=0.021, respectively). Group B patients experienced more locoregional recurrences (11.0%, P=0.025); similarly, more distant metastases were observed in Group B (15.3%, P=0.003). The 10-year disease-free survival rates were 87.6% in Group A and 70.8% in Group B (P<0.0001). Conclusion: Differentiated thyroid cancer in patients aged above 60 years are more aggressive biologically and associated with a worse prognosis, and the morbidity is significantly high as compared to patients aged below 60 years. Keywords: differentiated thyroid cancers, patients aged above 45 years, aged above 60 years, clinicopathological characteristics, treatment outcomes, elderly patients, aged below 60 years, comparative analysis
first_indexed 2024-12-18T01:43:41Z
format Article
id doaj.art-ff6fa28af47843d2b0fe0b45c897b11f
institution Directory Open Access Journal
issn 1178-1998
language English
last_indexed 2024-12-18T01:43:41Z
publishDate 2016-08-01
publisher Dove Medical Press
record_format Article
series Clinical Interventions in Aging
spelling doaj.art-ff6fa28af47843d2b0fe0b45c897b11f2022-12-21T21:25:15ZengDove Medical PressClinical Interventions in Aging1178-19982016-08-01Volume 111169117428624Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 yearsAL-Qahtani KHTunio MAAsiri MABayoumi YBalbaid AAljohani NJFatani HKhalid Hussain AL-Qahtani,1 Mutahir A Tunio,2 Mushabbab Al Asiri,2 Yasser Bayoumi,3 Ali Balbaid,2 Naji J Aljohani,4 Hanadi Fatani5 1Department of Otolaryngology-Head & Neck Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Department of Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia; 3Department of Radiation Oncology, NCI, Cairo University, Cairo, Egypt; 4Department of Endocrinology and Thyroid Oncology, 5Histopathology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia Introduction: The aim of this study was to evaluate the treatment outcomes of differentiated thyroid cancer in Saudi patients aged above 60 years. Materials and methods: Comparative analysis was performed in 252 patients aged 46–60 years (Group A) and 118 patients aged above 60 years (Group B), who had thyroidectomy, radioactive iodine-131, and thyroid-stimulating hormone suppression therapy between July 2000 and December 2012. Different clinicopathological features, treatment, complications, disease-free survival, and overall survival rates were compared. Results: Mean age of patients in Group A was 51.9 years (range: 46–60), and mean age of those in Group B was 68.6 years (range: 62–97). Group B patients had higher positive lymph nodes (43.2%), P=0.011. The frequency of extrathyroidal extension, multifocality, and lymphovascular space invasion was seen more in Group B than in Group A. Postsurgical complications (permanent hypoparathyroidism, bleeding, and wound infections) were also seen more in Group B (P=0.043, P=0.011, and P=0.021, respectively). Group B patients experienced more locoregional recurrences (11.0%, P=0.025); similarly, more distant metastases were observed in Group B (15.3%, P=0.003). The 10-year disease-free survival rates were 87.6% in Group A and 70.8% in Group B (P<0.0001). Conclusion: Differentiated thyroid cancer in patients aged above 60 years are more aggressive biologically and associated with a worse prognosis, and the morbidity is significantly high as compared to patients aged below 60 years. Keywords: differentiated thyroid cancers, patients aged above 45 years, aged above 60 years, clinicopathological characteristics, treatment outcomes, elderly patients, aged below 60 years, comparative analysishttps://www.dovepress.com/comparative-clinicopathological-and-outcome-analysis-of-differentiated-peer-reviewed-article-CIADifferentiated thyroid cancerspatients aged above 45 yearsaged above 60 yearsage below 60 yearsclinicopathological characteristicstreatment outcomeselderly patients. comparative analysis
spellingShingle AL-Qahtani KH
Tunio MA
Asiri MA
Bayoumi Y
Balbaid A
Aljohani NJ
Fatani H
Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
Clinical Interventions in Aging
Differentiated thyroid cancers
patients aged above 45 years
aged above 60 years
age below 60 years
clinicopathological characteristics
treatment outcomes
elderly patients. comparative analysis
title Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
title_full Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
title_fullStr Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
title_full_unstemmed Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
title_short Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
title_sort comparative clinicopathological and outcome analysis of differentiated thyroid cancer in saudi patients aged below 60 years and above 60 years
topic Differentiated thyroid cancers
patients aged above 45 years
aged above 60 years
age below 60 years
clinicopathological characteristics
treatment outcomes
elderly patients. comparative analysis
url https://www.dovepress.com/comparative-clinicopathological-and-outcome-analysis-of-differentiated-peer-reviewed-article-CIA
work_keys_str_mv AT alqahtanikh comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT tunioma comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT asirima comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT bayoumiy comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT balbaida comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT aljohaninj comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT fatanih comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years